Drug Pipeline
Gaucher disease
Rare genetic disorder due to defective lysosomal enzyme.
Current treatment: ₹3 million/ year/ 10 kg patient (lifelong IV, every two weeks).
Dengue viral infection
Global problem, no approved drug, severity high across LMICs (India, etc).
Dengue is a macrophage-tropic virus.
Antimicrobial resistance
Major global challenge with pathogens increasingly resistant to antibiotics and drug pipeline has run dry.
Many AMR microbes hide inside macrophages, shielded from antibiotics.
Breast cancer imaging
Breast cancer surgery guided by sentinel lymph node biopsy remains the first line of treatment in 90% of cases. But current imaging agents suffer preparation losses and low spatial resolution.
Tumor micro-enviorenments are enriched in tumor associated macrophages.
Completed
Ongoing